All News
ACR20 - Day 2 Report
Saturday was the day 2 with many posters and live sessions at the 2020 Virtual ACR/ARP meeting. Here are a few of my highlights from day two:
Read Article
Mepolizumab (anti-IL5) shown to be clinically beneficial and well-tolerated in the long-term for patients with #EGPA, with a 50% reduction in #steroid dose in the study cohort.
Abs#1427 #ACR20 @RheumNow #Vasculitis
https://t.co/elr6VR7447
Mrinalini Dey DrMiniDey ( View Tweet)
Dr Juge @Juge_P_A reports on prevalence of subclinical RA-ILD as identified by HRCT. At mean disease duration of 13 years 18.2% of patients had subclinical RA-ILD. @rheumnow #ACR20 Abstr#1199 https://t.co/VWKFxwFfIJ
Richard Conway RichardPAConway ( View Tweet)
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by @RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Dr Lee reports on risk of melanoma and NMSC risk in RA in cohort study using propensity score matching. No difference in risk between MTX and HCQ overall. Increase BCC in MTX (HR 1.32) but less SCC (HR 0.77) @rheumnow #ACR20 Abstr#1001 https://t.co/LDWgfGK9LS
Richard Conway RichardPAConway ( View Tweet)
5yr DESIR cohort data estimated incidence rate of uveitis at 1.3/100p-y; over five years, uveitis was associated w/ dactylitis, biologic and sacroiliac MRI inflammation. #ABS1304 #ACR20 @RheumNow https://t.co/qmXlY7PmBB
Dr. Rachel Tate uptoTate ( View Tweet)
Important thoughts- how do we actually use the biologics in practice for the rare diseases that do not have many FDA approved options? @RheumNow #ACR20 abstract 1429 https://t.co/SsYC1kF5uv
alexa meara lexmeara ( View Tweet)
Shifting Treatment Paradigms in Psoriatic Arthritis: Dr. Eric Ruderman (@JointMD)
Chicago-based Dr. Eric Ruderman discussed the shifting treatment paradigms in psoriatic arthritis by reviewing abstracts #0504 and #2026 at #ACR20.
https://t.co/jsLkgWG63v https://t.co/h3r2oapOij
Links:
Dr. John Cush RheumNow ( View Tweet)
Nintedanib in rheum ILD (RA/SSc/CTD)
I appreciate the volumes might not seem like much, but:
- in first 1y Rx 20% more are spared a FVC decline>10%
- biggest diff in UIP-like pattern
With the right patient selection, nintedanib does have its place!
#ACR20 ABST1048/1049 @RheumNow https://t.co/jGZdR84bBU
David Liew drdavidliew ( View Tweet)
Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly declined in this population from 1998 to 2014.
Abs#1423 #ACR20 @RheumNow
https://t.co/TTI4DJiCRk
Mrinalini Dey DrMiniDey ( View Tweet)
Corkscrew hairs and swollen knee - what's your diagnosis? TM01 #ACR20 @RheumNow https://t.co/jOkI94AKr6
Eric Dein ejdein1 ( View Tweet)
Please take the new telemedicine survey- how can we help our patients during these unique times! @RheumNow #ACR20 https://t.co/n2jFfh1N9N
alexa meara lexmeara ( View Tweet)
So much more work to be done- the traditional tools for estimating CVD in rheumatic patients are likely not accurate especially patients with SLE- abstract 1286 @RheumNow #acr20 https://t.co/L6Z1fsO2he
alexa meara lexmeara ( View Tweet)
#ABS1303 shows ASAS modification of Berlin algorithm showed optimal balance between sensitivity and specificity and represented the preferred referral strategy for patients presenting w/ undiagnosed back pain & extra-articular features. #ACR20 @RheumNow https://t.co/10VdKC3E75 https://t.co/RgC7K3V8TB
Dr. Rachel Tate uptoTate ( View Tweet)
Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts >75yrs less likely to be treated w/ immunosuppression & steroids but do benefit from this treatment when it is required.
Abs#1417 #ACR20 @RheumNow
https://t.co/stTAcioiQG
Mrinalini Dey DrMiniDey ( View Tweet)
Excellent case - great job! @RheumNow #ACR20 #TM05 https://t.co/obE7KLD68m
Eric Dein ejdein1 ( View Tweet)
Dr @AliDuarteMD presents on incidence of SLE over last 40 years, 29% increase overall, and doubled in males. Overall cyclical pattern. Abstr#1024 #ACR20 @rheumnow https://t.co/SSVY0U0SIg
Richard Conway RichardPAConway ( View Tweet)
#sjogren #syndrome poster session #ACR20 @RheumNow Clinical characteristics: lung, pregnancy,smoking, cervical lesions, anti La, childhood. https://t.co/QN4FVvQrYN
Sole RetamozoSole ( View Tweet)
Great Thieves Market poster by my @jhrheumatology co-fellow Dr. James Son. 27 yo patient with active myositis has this imaging. Check it out for diagnosis! @RheumNow #ACR20 https://t.co/xUT6QkWNAX
Eric Dein ejdein1 ( View Tweet)
The RheumNow podcast on #ACR20 Day 2 Part I is now available for download. Follow the link below to listen in or find us on Apple.
https://t.co/VAPnzYtCIK https://t.co/kD4lNltMsw
Links:
Dr. John Cush RheumNow ( View Tweet)